Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 55,454	$ 80,336
Marketable securities	188,293	153,721
Prepaid expenses and other current assets	5,854	6,124
Total current assets	249,601	240,181
Property and equipment, net	9,964	12,956
Restricted cash	1,708	1,708
Other assets	68	1,115
Operating lease right-of-use assets	22,641	29,956
Total assets	283,982	285,916
Current liabilities:
Accounts payable	3,785	6,260
Accrued expenses and other current liabilities	8,531	9,108
Operating lease liabilities	9,067	8,518
Deferred revenue	45,606	34,550
Total current liabilities	66,989	58,436
Operating lease liabilities, net of current portion	28,064	36,555
Deferred revenue, net of current portion	234,457	268,115
Total liabilities	329,510	363,106
Commitments and contingencies (Note 11)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; 25,000,000 shares authorized as of December 31, 2024 and 2023; no shares issued and outstanding as of December 31, 2024 and 2023	0	0
Common stock, $0.0001 par value; 175,000,000 shares authorized at December 31, 2024 and 2023; 55,594,131 shares issued and outstanding at December 31, 2024 and 42,282,040 shares issued and outstanding at December 31, 2023	6	4
Additional paid-in capital	512,515	395,196
Accumulated other comprehensive gain (loss)	135	(826)
Accumulated deficit	(558,184)	(471,564)
Total stockholders’ deficit	(45,528)	(77,190)
Total liabilities and stockholders’ deficit	$ 283,982	$ 285,916